Versigent

VGNT · NYSE

$43.87+$0.18 (+0.41%)TodayMarket closed ·
Prev close $43.69

About VGNT

Versigent Plc engages in the design, manufacturing, supplies low voltage and high voltage electrical architectures for automotive and commercial vehicle markets. The company is headquartered in Schaffhausen, Schaffhausen and currently employs 138,000 full-time employees. The company went IPO on 2026-04-01. The firm is primarily engaged in the automotive components and electrical systems industry. The firm focuses on the design, development, manufacturing, and delivery of signal, data, and power distribution systems for vehicle applications. Their core offerings include electrical architectures as well as physical electrical distribution products.

Employees
138,000
Headquarters
Schaffhausen, Schaffhausen
Listed
Apr 1, 2026
Sector
Consumer Discretionary
Industry
Auto Components

VGNT key statistics

Market cap
3.13B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
668.75K
Volume
605.36K
Open price
$43.41
High today
$44.29
Low today
$43.19
52 Week high
$50.89
52 Week low
$26.34

Versigent (VGNT) at a glance

Versigent (VGNT) last traded at $43.87, with a market cap of 3.13B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $43.19 and $44.29. The current price is 1.6% above the day's low and 0.9% below its high.

Volume so far is 605.36K shares, in line with the average of 668.75K shares a day.

Over the past year Versigent has ranged from $26.34 to $50.89, and now sits 71% of the way up that range.

Versigent met or beat analyst EPS estimates in 1 of the last 2 quarters. In Q2 FY26 it reported $1.64 per share against an estimate of $1.54.

The average analyst price target is $57.12, 30.2% above the current price, from 8 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 8 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 11 analystsAvg $57.12
Low
$52.52
Now
$43.87
High
$63.00

VGNT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 2 quarters, by 6.3% on average.

  1. Q1 FY26: reported $1.10 per share against an estimate of $1.23
  2. Q2 FY26: reported $1.64 per share against an estimate of $1.54

VGNT news

  • Press releaseBusiness Wire

    Versigent Announces Third Quarter 2026 Earnings Call Details

  • Versigent Q2 2026 Earnings Call Transcript

  • Press releasePRNewswire

    Bloomberg 500 (B500) Index Adds Ten Securities Following September Reconstitution

  • Chris Katje

    David Einhorn Has 7 New Stock Picks: Hedge Fund Manager Bets on Buyouts, Spinoffs

  • Press releaseBusiness Wire

    Versigent Reports Second Quarter 2026 Results

  • Press releaseBusiness Wire

    Versigent Announces Second Quarter 2026 Earnings Call

  • Piero Cingari

    S&P 500, Nasdaq 100 Drop From Records As Rate-Hike Bets Build, Oil Climbs: Stock Market Today

  • Press releaseBusiness Wire

    Versigent Announces Participation in June Investor Conferences

Similar companies

Companies in the same industry as Versigent

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.